Temporary bypass during liver transplant to help extended-donor livers
Part of Digestive system clinical trials.
This trial studies a temporary surgical bypass during liver transplantation to improve how well the new liver works, especially when the donor liver is “extended criteria.” It may help patients whose transplant plan includes a higher-risk donor liver by testing whether the bypass better protects the graft.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are a candidate for a liver transplant because of cirrhosis
- Your MELD score is under 25
- Your transplant would use a donor liver that has at least one higher-risk feature (like older donor age or high BMI)
- You agree to take part in the study (no refusal)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial explores using smaller liver grafts in a partial transplant to treat portal hypertension, which may help patients avoid full transplant risks. It compares this approach to standard liver transplant.
This trial tests whether using a machine to keep donated livers healthy (normothermic machine perfusion) can allow more people to receive a transplant sooner. It is for patients who are already on the waiting list for a liver and have a moderately severe MELD score (25 or less).
This study uses a tiny probe placed in the new liver during transplant surgery to monitor its health in real time. It may help doctors detect problems early and improve recovery after transplant.
This trial tests a new way to preserve donated livers with a machine called eXVIVO before transplant. It is for adults receiving their first liver transplant and aims to see if this preservation method improves outcomes.
This trial tests a procedure to lower blood loss during liver transplant for patients with high blood pressure in the liver. It may help those who have had a previous transplant, abdominal surgery, or certain complications of liver disease.
This trial studies whether using an “ex vivo perfusion” process—keeping a donor liver alive outside the body before transplant—can improve outcomes for certain people who need a liver transplant but have limited options. It may help patients who are too high-risk for standard transplant timing or options, including some cancer-related liver disease cases.
Hear when a new Liver Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.